menu search

A couple of light releases on the agenda in europe today

The dollar is keeping steadier so far on the day, after posting a decent advance in trading yesterday owing much to a surge higher in USD/JPY. The pai...

November 1, 2023, 5:24 am

Astrazeneca inks gene editing deal that could end up costing it $2.5bn

AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist biotech firm Cellectis (NASDAQ:CLLS) ...

November 1, 2023, 3:59 am

Astrazeneca signs drug development deal with biotech cellectis

AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage biotechnology company Cellectis to spee...

November 1, 2023, 3:17 am

Argenx to present at upcoming investor conferences

November 1, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop...

November 1, 2023, 2:00 am

Worthington industries (wor) increases yet falls behind market: what investors need to know

In the latest trading session, Worthington Industries (WOR) closed at $61.62, marking a +0.55% move from the previous day....

October 31, 2023, 7:32 pm

Siemens ag (siegy) increases yet falls behind market: what investors need to know

Siemens AG (SIEGY) closed at $66.19 in the latest trading session, marking a +0.39% move from the prior day....

October 31, 2023, 7:32 pm

Amgen gets fda approval for its inflammatory diseases treatment wezlana

Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory dis...

October 31, 2023, 7:22 pm

Usd/cad: values firm before data releases brings volatility

The USD/CAD appears for the moment to be in a rather calm trading range. However, the rather steady value around 1.38200 is probably going to vanish �...

October 31, 2023, 6:59 pm

Copa holdings (cpa) increases yet falls behind market: what investors need to know

Copa Holdings (CPA) closed the most recent trading day at $81.65, moving +0.23% from the previous trading session....

October 31, 2023, 6:47 pm

U.s. fda approves amgen's biosimilar vesrion of j&j's stelara

The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment Stelara fo...

October 31, 2023, 6:32 pm

Lirum therapeutics presents positive data on lx-101, a novel clinical-stage targeted therapy, demonstrating potent preclinical activity against pediatric sarcomas

New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focuse...

October 31, 2023, 5:27 pm

Edp renewables net profit increases to 467 million euros in the first nine months of 2023

Madrid, Oct. 31, 2023 (GLOBE NEWSWIRE) — Recurring net profit in the first nine months of 2023 increased 12% compared to the same period in 2022, an...

October 31, 2023, 5:22 pm

Astronics stock could be a buy but risks remain

Astronics Corporation is a provider of advanced technologies to the aerospace, defense, and electronics industries. The company has exposure to growth...

October 31, 2023, 5:10 pm

Several midstream companies grow q3 dividends

A handful of midstream names have already announced increases to their dividends. The midstream segment...

October 31, 2023, 3:29 pm

Eur/usd – eurozone inflation eases further than expected, us eci a minor concern

Eurozone HICP inflation falls to 2.9% in October US ECI rises to 1.1% in Q3 EURUSD continues to look weak Inflation in the eurozone fell below 3% in O...

October 31, 2023, 3:05 pm

Eurozone inflation eases further than expected, us eci a minor corncern, boj tweak triggers yen slide

Inflation in the eurozone fell below 3% in October, with energy and food prices helping to push the headline number even lower than expected. While th...

October 31, 2023, 2:45 pm

Cytokinetics exploring options after receiving takeover interest - bloomberg news

Heart diseases-focused drug developer Cytokinetics is weighing options after receiving takeover interes...

October 31, 2023, 2:26 pm

3 millionaire-maker growth stocks to buy now (and never sell!)

While 2023 was a year of relative outperformance for equities, select high-growth stocks saw their growth slow due to uncertainties like recession fea...

October 31, 2023, 2:00 pm

China: momentum waned in october

PMI data for October showed momentum in China's economy waned following recent improvements in hard activity data. By industry type, most manufacturin...

October 31, 2023, 1:59 pm

Nasdaq composite technical analysis

Nasdaq Composite AnalysisThe Nasdaq Composite opened the week as expected with a small bounce as the risk sentiment improved given no escalation on th...

October 31, 2023, 1:03 pm


Search within

Pages Search Results: